Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That would take a marketing budget and staff which they are not capitalized to handle. That’s why it make no sense that a pharma with supposedly disruptive tech would exclusively license anything to Gpft who’s only accomplishment is to have processing and a distribution license but is unable to turn a profit or at least break even!
Qsep is perpetually Financed by convertibles and is essentially a license to dilute till they run out of gimmicks...then I would expect management will sell or reverse merge the shell with some other entity looking to be public and start anew! It’s a two decade shell game!
Again if one doesn’t know the terms, fee structure and territory of a licensing agreement, then it’s impossible to calculate margins and therefore ROi. This is the modus operandi....insinuate they have exclusivity but in reality it’s all shrouded in secrecy...feel free to address the issue of why the pharma and Licensor would rely on a penny stock financed by convertible notes to be the driving distributor of a supposedly disruptive product. I can’t wait for the analysis.,.this should be good!
The licensing agreement is redacted as to term,territory and free structure. So it’s basically just used a fluff doc to stroke the excitement of another money loosing year!
Licensing of a product usually requires the licensee to acknowledge the underlying tech which they are not required to do in a fluff campaign but months ago the argument here was that gpft owned the IP which they clearly don’t but suggestively word releases as if they do. Also the territories are restricted and the actual licensing costs are unknown. It’s redacted in the agreements making it impossible to estimate margins. Financially the company does not look like they are ready to rollout some major product disruptor. Ceo and Bro will make bank but the common holder will get crushed. If the tech is truly disruptive the pharma would never give it to an unproven operator with not enough cash to get a proper roll out. They are well funded public companies now in this space. It is illogical they would they pick a merged shell with all kinds of previous problems! If it walks like a duck....
Qsep headed for sub penny. It is as clear as day. Company is a compilation of failure after failure and billed as promising because investors who become management continue to finance this sinking ship. Honestly basing an investment decision for a multi decade old money loosing company because of engineered insider purchases is a reckless strategy that has put this company at .02 cents! .02 will look like the great pyramids of Egypt in a few months.
Interesting they promote this as “patented” but say nothing about the pharma that is the patent holder which implies that gpft owns the patent....which clearly do not.
If CEO is making deliveries chances are he doesn’t have a clue about social media marketing campaigns or the budget to do so. They bleed cash every month...medical Fluoroscope company turn weed distributor!!! Only in America!
.30 is a market cap of 150M! Can’t be the anemic sales and even lower margins as this company is one bong hit from collapsing into nothingness.
They will reverse merge into a cannabis or cypto company. Seems to be the rage these days!
Qsep may only have fluff to sell but they have plenty of salesmen! This company is in the business of selling convertibles. They throw up a product Hail Mary every time they rebrand its management yet it products always gets swatted down! This is professional kool aide peddling of which I would concede Qsep is an expert! As far as disrupting the laws of Mother Nature...they have never been remotely close. It’s a sad story of how to blow a hundred million dollars pretending you have something big. The human comedy of it all is that management makes the same promises year after year and it become the party line!
Not much they could say. They will just regurgitate the 10q. Basically in a nutshell No sales.. and they still haven’t figured out why Aot shorts to ground every time it turns on....oh and btw they will need to raise more money cause qsep is insolvent! Other than that things are hunky dory!
Nothing surprising about that...gpft merged with a shell that milked investors for a decade. It’s only fitting that the merged entity continue the Malfeasance.
Don’t forget Whacky Prof Tao...not too much mention of his brilliant discoveries like the 1000 ft high Tornado wall. I assume it’s been profitable for Tao to keep writing his bogus white papers that never produce a viable product anywhere but one would think a technical figurehead of the company would strive to make it actually work! But as we have see, as long as the money get raised it’s just another day in paradise as they all will get a paycheck.
Then there is Temple university who is happy to let this so called major disruptive discovery waddle in obscurity for a decade for a mere $187k a year in license fees which are in arrears to the tune of over $1M. They also get big chunk of commission on any sale.This extortion has been ongoing on for years! No right minded university would license a tech they cannot prove. That in itself is in my mind a fiduciary breach of great magnitude. Tough to prove but someday someone will take stab at it! Universities should be restricting from selling legitimacy when it’s obvious no new technology has been discovered and deployed.
Rasmussen must still be on the payroll but I wonder about the consultant guru who was supposedly the answer to all the technical questions! He got a nice payday..I’ll bet he got a chunk of that 500k “work order” money! Even the best engineer in the world cannot defy the laws of Mother Nature. That’s what Qsep products are based on...a property that has not been proven to have any measured effectiveness while posing a significant safety threat.
Qsep has been done since it’s first test bombed at TCPL over 7 years ago! 4 CEO’s later and a litany of creative excuses didn’t stop the momental price declines that can point to only one conclusion. This company has failed in proving the efficacy of its product. Even with a half baked professor declaring it works as promised, the magic AOT can’t turn on under pressure without ground faulting. Nobody is putting a potential bomb on a pipeline! The company has less than 50k in cash as of the MRQ. They owe over a million to Temple for its bullsh$t license which now is collecting 10% interest per year and adds 187k each year in MSU ten each fees. All while selling nothing! CFO is the only one still getting paid while he conducts business from his wet bar. Former CEO payoff also in arrears. If they find more sucker money they might extend for another a year or two but ultimately sub penny in the next 12-24 months.
Q is out...can’t wait to hear all the golden nuggets that some will suddenly discover “in between” the lines of actual facts! Don’t worry about the 53k in cash left and mounting expenses...I have been saying that years!it’s obvious it had no effect on management from being this disruptive tech to market and then having its “ paid testing partner” laugh all the way to the bank! See the owe Bigger money still! Expect that lawsuit to drop any day...
Yep I figure 100 scoobie doo playground sets can be fabricated from only one Aot! That’s an Roi of .00000000001%. That should cause the hand over fist buying that’s been promised every year for a decade!
PR is just made up optimism. When you can see it hit the bottom line then it can be discussed as a valuable metric...until then its just flufferized air!
Still awaiting your proof that this equity has value. No real mention of its patchless nonsense just more excuses why they have a gross profit margin of 14% on sales of a decent size liquor store and lose a boatload of cash they don’t have. They just received the final tranche of $ 1 million which gives them less than a year in operations. This is a hardway bet with only one die!
Seem to be the natural progression of failed OTC companies that just happen to merge with other murky entities in the cannabis market. Big hype then poof...up in smoke!
Company is exploding debt and the dilution train keeps chugging as their debt keeps rising exponentially. Gross profit margin tells the whole story. 14% for the Q doesn’t cut the mustard for much longer. Youris brothers maybe great mall lawyers but they are not suited to run a public company. At 14%gross margin they would need to increase sales at least 500% in the short term just to cover the nut!
What’s to compute? No sales no cash just expenses. This fish is dead and has been on the dock for weeks laying in the sun!
I’m betting it’s cannabis!
“
Believe it or not, I can remember when imaging 3 was once on the NASDAQ. The stock price fell below the minimum and they dropped them.”
I don’t think so...they did uplist within tiers of the OTC but not the NASDAQ.
“
If businesses were all classified as scams because of ugly things in their past, the DOW would collapse tomorrow, the lights would go off and we’d be back to being farmers in no time flat.”
Ummm...In the exchanges outside of the OTC you have minimum financial metrics that need to be maintained. Scams usually don’t make it that far in the Nasdaq or other major exchanges as they can never produce the sales and market cap to get up listed. Not so true for the OTC especially the lower tiers. The reality is whether Imaging 3 is called a scam or continuously money loosing venture...it really matters little. The OTC is filled with con artists waiting to separate investors from their money. The failure rate for these companies is high double digits.
DvIS was more like a college experiment pawned off as a ready viable product...which is not necessarily a scam but pretty close.. especially if you examine what the FDA concluded as to imagery. Besides, Medtronic owned that market with the “breakaway” c-arm and could throw millions in R&D at that market. Management used money intended for R&D for personal enrichment and to spend lavishly on trade shows when there were no position to sell anything except paper.
Fair enough!
“
Are we going to tar the "Y Brothers" with the Dean Janes brush just because of the sins of the past?”
I’m not tar and feathering anyone. It just doesn’t make sense to do a reverse acquisition to be an OTC penny stock. They need financing to the tune of 10-20M so why would they want to attach themselves to a burned out shell that screwed thousands of investors? Again a question of logical thinking. As far as DJ you know he still owns a majority of the pre acquisition shares. He didn’t suddenly give those up.
The proto that supposedly was the next generation was held hostage by the engineering company for lack of payment. Never heard a word after that. The blue beast as we called it was the one and only.
Wrong only made $ on imaging3 but it was completely luck as a family member requested I buy some on her behalf and it was later willed to me. After reviewing the disclosures and the company’s idiotic Money Tv spots with old huckster Don Ballargeron, it was a very simple call to spot the deception and slippery management.
Let gets the facts straight shall we...Dean janes the founder and CEO of imaging3 used misrepresentation to keep his company afloat for a decade . He was sanctioned by the SEC years ago and removed as CEO and banned from being an officer of any public company. He poured tons of public money into his facility which he owned and even stiffed the design company who designed the company outrageous peninsula style trade show booth which highlighted the companies incomplete untested product that could not pass the smell test. The company made several failed tries to get it through FDA clearance. Finally after the last FDA NSE response he lied again and was exposed.
Many of these operation spiff up their facilities...it’s not their money they are burning!
Didn’t say it was an outright scam but one must assume it’s another gimmick product until black hits the bottom line. The question is if it’s so good why roll the dice with a small undercapitalized company financed by convertibles and have yet to turn into a viable cash generating business? Green thumb has 200 M in cash. I wonder what deal they would be offered.
Dude...I’ve seen this many times before. The GPFT sizzle is way more enticing then the actual steak. When the celebration and condemnation starts way before the goods hit the market that its likely just another dog with fleas.
No personal attack. It’s a clear fact that the Y brothers make more in salaries than the entire up front multi year licensing fees for the supposed game changing application. If you like to refute that then let’s hear it.
“Grapefruit paid the Patent holder $5,000.00 and issued it 100,000 shares of IGNG common stock on execution of the MOU. When the parties reach a formal license agreement Grapefruit shall pay the Patent Holder $50,000.00 in two installments of $25,000.00 each and shall issue 1,000,000 shares of IGNG common stock to the Patent Holder. Grapefruit will have 8 months from the actual technology transfer to commercialize the first ‘patchless patches” and shall pay a decreasing royalty of between 4 and 7% of revenues to the Patent Holder depending on the level of revenue achieved.”
So this alleged disruptive game changing tech gets licensed to (Ca,IL) granted for only 2.5 years for only 55k cash and approx 40k in stock!!!haha haha!!!!! The Yourist brothers make per year in salaries. So there goes the entire US exclusivity argument and confirms gpft is one many that will sign this agreement.
What IP is that? A licensee has no claim on the patent rights. They are licensing a delivery system that so far unproven in market. Now if gpft is claiming they adding some unknown methodology into the mix then it could be claimed. Until then it’s more smoke.
Oh..,like gpft is the only company that has cannabis licensing?? Please much larger fish in the sea that this nano cap.
But wait...it’s been repeated like a mantra that gpft “owns” the patent...oh but now they just have an exclusive distributorship.. check that... now it’s only for Cali and Canada with no terms, payments and time period released. Ha! Not so exclusive.
It’s not exclusive and there are stated territories and terms...which are conveniently redacted. The pharma owns the patent and would be stupid to only allow one operator to control 100% of US distribution. It’s standard penny stock sales puffery that hasn’t change with a new ticker.
Company infers it has patented this application which is not true. They are simply a licensee. These are fluff releases. They bought some blending and packaging equipment. Big whoop!